Neuroprotective effect of berberine agonist against impairment of learning and memory skills in severe traumatic brain injury via Sirt1/p38 MAPK expression

Wang,Jianping; Zhang,Yamin

doi:10.3892/mmr.2018.8674

Neuroprotective effect of berberine agonist against impairment of learning and memory skills in severe traumatic brain injury via Sirt1/p38 MAPK expression

Authors:
- Jianping Wang
- Yamin Zhang
View Affiliations

Affiliations: Department of Emergency, Gansu Provincial Hospital, Lanzhou, Gansu 730000, P.R. China, Department of Neurological Rehabilitation, Gansu Provincial Hospital, Lanzhou, Gansu 730000, P.R. China
Published online on: March 5, 2018 https://doi.org/10.3892/mmr.2018.8674
Pages: 6881-6886

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Berberine has multiple clinical applications, including the treatment of tumors, diabetes, cardiovascular diseases, hyperlipidemia, inflammation, bacterial and viral infections, cerebral ischemic injuries, mental diseases, Alzheimer's disease and osteoporosis. In the present study, the neuroprotective effect of berberine agonist rescue learning and memory in severe traumatic brain injury (TBI), and the possible mechanism underlying these observations was explored. The protective effect of berberine agonist significantly recovered learning and memory skills, attenuated brain edema and inhibited matrix metalloproteinase‑3 and ‑9 protein expression in mice with severe TBI. Berberine agonist significantly reduced inflammation, oxidative stress and apoptosis levels in mice with severe TBI. Berberine agonist promoted choline acetyltransferase activity and inhibited the activity of acetylcholinesterase. Collectively, results of the present study revealed that the neuroprotective effect of berberine agonist rescues learning and memory skills in severe TBI.

View Figures

View References

1	Wade SL, Kurowski BG, Kirkwood MW, Zhang N, Cassedy A, Brown TM, Nielsen B, Stancin T and Taylor HG: Online problem-solving therapy after traumatic brain injury: A randomized controlled trial. Pediatrics. 135:e487–e495. 2015. View Article : Google Scholar : PubMed/NCBI
2	Hammond FM, Alexander DN, Cutler AJ, D'Amico S, Doody RS, Sauve W, Zorowitz RD, Davis CS, Shin P, Ledon F, et al: PRISM II: An open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurol. 16:892016. View Article : Google Scholar : PubMed/NCBI
3	Wang X, Ji J, Fen L and Wang A: Effects of dexmedetomidine on cerebral blood flow in critically ill patients with or without traumatic brain injury: A prospective controlled trial. Brain Inj. 27:1617–1622. 2013. View Article : Google Scholar : PubMed/NCBI
4	Saxena MK, Taylor C, Billot L, Bompoint S, Gowardman J, Roberts JA, Lipman J and Myburgh J: The effect of paracetamol on core body temperature in acute traumatic brain injury: A randomised, controlled clinical trial. PLoS One. 10:e01447402015. View Article : Google Scholar : PubMed/NCBI
5	Du G, Zhao Z, Chen Y, Li Z, Tian Y, Liu Z, Liu B and Song J: Quercetin attenuates neuronal autophagy and apoptosis in rat traumatic brain injury model via activation of PI3K/Akt signaling pathway. Neurol Res. Oct 3–2016.(Epub ahead of print). View Article : Google Scholar :
6	Chuang CH, Hsu YC, Wang CC, Hu C and Kuo JR: Cerebral blood flow and apoptosis-associated factor with electroacupuncture in a traumatic brain injury rat model. Acupunct Med. 31:395–403. 2013. View Article : Google Scholar : PubMed/NCBI
7	Hu ZG, Wang HD, Qiao L, Yan W, Tan QF and Yin HX: The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats. Brain Inj. 23:459–465. 2009. View Article : Google Scholar : PubMed/NCBI
8	Yang Y, Wang Q, Xie M, Liu P, Qi X, Liu X and Li Z: Berberine exerts an anti-inflammatory role in ocular Behcet's disease. Mol Med Rep. 15:97–102. 2017. View Article : Google Scholar : PubMed/NCBI
9	Habtemariam S: Berberine and inflammatory bowel disease: A concise review. Pharmacol Res. 113:592–599. 2016. View Article : Google Scholar : PubMed/NCBI
10	Ma L and Zhang L, Wang B, Wei J, Liu J and Zhang L: Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9 via PI3K. Eur J Pharmacol. 755:102–109. 2015. View Article : Google Scholar : PubMed/NCBI
11	NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group, . Finfer S, Chittock D, Li Y, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Hebert P, et al: Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: Long-term follow-up of a subgroup of patients from the NICE-SUGAR study. Intensive Care Med. 41:1037–1047. 2015. View Article : Google Scholar : PubMed/NCBI
12	Matuseviciene G, Borg J, Stålnacke BM, Ulfarsson T and de Boussard C: Early intervention for patients at risk for persisting disability after mild traumatic brain injury: A randomized, controlled study. Brain Inj. 27:318–324. 2013. View Article : Google Scholar : PubMed/NCBI
13	Nägeli M, Fasshauer M, Sommerfeld J, Fendel A, Brandi G and Stover JF: Prolonged continuous intravenous infusion of the dipeptide L-alanine-L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury. Crit Care. 18:R1392014. View Article : Google Scholar : PubMed/NCBI
14	Liu S, Zhang L, Wu Q, Wu Q and Wang T: Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury. J Mol Neurosci. 51:1021–1029. 2013. View Article : Google Scholar : PubMed/NCBI
15	Ge X, Huang S, Gao H, Han Z, Chen F, Zhang S, Wang Z, Kang C, Jiang R, Yue S, et al: miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 1650:31–40. 2016. View Article : Google Scholar : PubMed/NCBI
16	Bentz K, Molcanyi M, Schneider A, Riess P, Maegele M, Bosche B, Hampl JA, Hescheler J, Patz S and Schäfer U: Extract derived from rat brains in the acute phase following traumatic brain injury impairs survival of undifferentiated stem cells and induces rapid differentiation of surviving cells. Cell Physiol Biochem. 26:821–830. 2010. View Article : Google Scholar : PubMed/NCBI
17	Liu SJ, Zou Y, Belegu V, Lv LY, Lin N, Wang TY, McDonald JW, Zhou X, Xia QJ and Wang TH: Co-grafting of neural stem cells with olfactory en sheathing cells promotes neuronal restoration in traumatic brain injury with an anti-inflammatory mechanism. J Neuroinflammation. 11:662014. View Article : Google Scholar : PubMed/NCBI
18	Reinhard SM, Razak K and Ethell IM: A delicate balance: Role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders. Front Cell Neurosci. 9:2802015. View Article : Google Scholar : PubMed/NCBI
19	Grossetete M, Phelps J, Arko L, Yonas H and Rosenberg GA: Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery. 65:702–708. 2009. View Article : Google Scholar : PubMed/NCBI
20	Wiggins-Dohlvik K, Merriman M, Shaji CA, Alluri H, Grimsley M, Davis ML, Smith RW and Tharakan B: Tumor necrosis factor-α disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9. Am J Surg. 208:954–960. 2014. View Article : Google Scholar : PubMed/NCBI
21	Wang Y, Fan X, Tang T, Fan R, Zhang C, Huang Z, Peng W, Gan P, Xiong X, Huang W and Huang X: Rhein and rhubarb similarly protect the blood-brain barrier after experimental traumatic brain injury via gp91phox subunit of NADPH oxidase/ROS/ERK/MMP-9 signaling pathway. Sci Rep. 6:370982016. View Article : Google Scholar : PubMed/NCBI
22	Dixon CE, Flinn P, Bao J, Venya R and Hayes RL: Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp Neurol. 146:479–490. 1997. View Article : Google Scholar : PubMed/NCBI
23	Cha Y, Lee SH, Jang SK, Guo H, Ban YH, Park D, Jang GY, Yeon S, Lee JY, Choi EK, et al: A silk peptide fraction restores cognitive function in AF64A-induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene. Toxicol Appl Pharmacol. 314:48–54. 2017. View Article : Google Scholar : PubMed/NCBI
24	Pineda RG, Neil J, Dierker D, Smyser CD, Wallendorf M, Kidokoro H, Reynolds LC, Walker S, Rogers C, Mathur AM, et al: Alterations in brain structure and neurodevelopmental outcome in preterm infants hospitalized in different neonatal intensive care unit environments. J Pediatr. 164(52–60): e22014. View Article : Google Scholar
25	Zhang J, Yang JQ, He BC, Zhou QX, Yu HR, Tang Y and Liu BZ: Berberine and total base from rhizoma Coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease. Saudi Med J. 30:760–766. 2009.PubMed/NCBI